New discussion around Parkinson’s treatment is putting dopamine agonists under the spotlight, with clinicians balancing motor benefits against behavioral side effects.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/parkinsons-treatment-are-dopamine-agonists-fading-2026a1000lqv?src=rss
Author :
Publish date : 2026-06-26 09:13:00
Copyright for syndicated content belongs to the linked Source.
